These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16416013)

  • 1. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.
    Millikan R; Eaton A; Worley K; Biscocho L; Hodgson E; Huang WY; Geradts J; Iacocca M; Cowan D; Conway K; Dressler L
    Breast Cancer Res Treat; 2003 Jun; 79(3):355-64. PubMed ID: 12846420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer.
    Ameyaw MM; Tayeb M; Thornton N; Folayan G; Tariq M; Mobarek A; Evans DA; Ofori-Adjei D; McLead HL
    J Hum Genet; 2002; 47(4):172-5. PubMed ID: 12166652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial screening of the rs104893657 variant of the PAX8 gene in women with hypothyroidism from Northeastern Slovakia.
    Mydlárová Blaščáková M; Homjáková B; Nagy M; Poráčová J; Lörinczová Z; Makovický P; Kimáková T; Sedlák V; Konečná M
    Cent Eur J Public Health; 2023 Dec; 31(Suppl 1):S89-S94. PubMed ID: 38272482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PROPDESC Score Validation (PROPDESC-Val)].
    Guttenthaler V; Kunsorg A; Mayr A; Hering T; Menzenbach J; Wittmann M
    Anaesthesiologie; 2024 Jan; 73(1):56-59. PubMed ID: 38172421
    [No Abstract]   [Full Text] [Related]  

  • 5. BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population.
    Bhatt D; Verma AK; Bharti PS; Goyal Y; Alsahli MA; Almatroudi A; Rahmani AH; Almatroodi S; Joshi PC; Alam MM; Ahmad I; Zaman GS; Dev K
    J Oncol; 2021; 2021():8865624. PubMed ID: 33708254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
    Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Her2
    Krishna BM; Chaudhary S; Panda AK; Mishra DR; Mishra SK
    Sci Rep; 2018 May; 8(1):7427. PubMed ID: 29743533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.
    Budiarto BR; Desriani
    Sci Pharm; 2016; 84(1):103-11. PubMed ID: 27110502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HER2 codon 655 polymorphism with ovarian cancer.
    Watrowski R; Castillo-Tong DC; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Tumour Biol; 2016 Jun; 37(6):7239-44. PubMed ID: 26666819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer.
    Ozturk O; Canbay E; Kahraman OT; Fatih Seyhan M; Aydogan F; Celik V; Uras C
    Mol Biol Rep; 2013 Feb; 40(2):1813-8. PubMed ID: 23086302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
    Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
    PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study.
    Qu S; Cai Q; Gao YT; Lu W; Cai H; Su Y; Wang SE; Shu XO; Zheng W
    Breast Cancer Res Treat; 2008 Jul; 110(1):169-76. PubMed ID: 17687647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
    Kamali-Sarvestani E; Talei AR; Merat A
    Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk.
    Cox DG; Hankinson SE; Hunter DJ
    Pharmacogenet Genomics; 2005 Jul; 15(7):447-50. PubMed ID: 15970791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.
    Riaz SK; Rashid MM; Kayani MA; Arshad Malik MF
    Arch Iran Med; 2016 Jun; 19(6):430-8. PubMed ID: 27293060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
    Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
    Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.